Description

Falsely low total serum calcium concentrations may be reported following exposure to certain gadolinium contrast agents for magnetic resonance imaging (MRI).


 

The falsely depressed total calcium result can result in:

(1) a normocalcemic patient being diagnosed as hypocalcemic

(2) a hypercalcemic patient being diagnosed as normocalcemic

 

Laboratory method affected: colorimetric assay for calcium

 

Contrast medium implicated:

(1) gadodiamide (Omniscan)

(2) gadoversetamide (OptiMARK)

 

Contrast medium not reported to cause this problem:

(1) gadopentetate dimeglumine (Magnevist)

(2) gadoteridol (ProHance)

 

Patients at risk for a problem:

(1) patients in the ICU (more laboratory testing done in period after an MRI)

(2) high dose (>= 0.2 mmol per kg body weight, > 20 mL) of contrast agent administered

(3) renal insufficiency (decreased excretion)

 

A person with normal renal function may be affected for the 12 hours after receiving the contrast agent. A patient with renal insufficiency may be affected for 24 hours.

 

Methods of handling:

(1) Use of a contrast agent that does not cause a falsely depressed total serum calcium level.

(2) Measure ionized calcium or total calcium by a noncolorimetric assay if in doubt.

(3) Delay measurement of total serum calcium until the contrast agent is cleared.

 


To read more or access our algorithms and calculators, please log in or register.